Fermentative Alpha-Ionone Production via Enzymatic Pathway Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing alpha-ionone, particularly (R)-alpha-ionone, are inefficient and result in impure enantiomeric forms, with natural sources requiring laborious enrichment and chemical synthesis producing racemic mixtures, while existing recombinant systems have low yields and substrate specificity limitations.
Innovation Solution
A method involving the culturing of microorganisms with heterologous nucleotide sequences encoding enzymes like geranylgeranyl-diphosphate-synthase, isopentenyl-diphosphate-isomerase, phytoene-desaturase/dehydrogenase, phytoene synthase, lycopene-epsilon-cyclase, and carotenoid-cleavage-dioxygenase to fermentatively produce enantiomerically pure alpha-ionone, specifically (R)-alpha-ionone, by optimizing the lycopene and epsilon-carotene biosynthesis pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If natural sources are used for alpha-ionone production, then the substance can be obtained through extraction, but laborious enrichment and purification steps are necessary and the yield is low
Solution Approach 1:
The patent extracts and utilizes specific enzyme genes (lycopene-epsilon-cyclase and CCD1) from natural sources and introduces them into microorganisms through genetic engineering. This allows the microorganisms to produce alpha-ionone fermentatively, eliminating the need for laborious extraction and purification from natural plant sources while achieving high yields of enantiomerically pure (R)-alpha-ionone.
Solution Approach 2:
The patent uses microorganisms as intermediary factories that have been genetically modified to express plant-derived enzymes. These microorganisms convert simple substrates into alpha-ionone through the introduced enzymatic pathways, serving as a bridge between simple fermentation processes and complex natural product synthesis, thereby simplifying manufacturing while maintaining high purity and yield.
2Productivity
If chemical synthesis is used for alpha-ionone production, then the substance can be produced in sufficient amounts, but racemic mixtures are formed with enantiomers of different scents
Solution Approach 1:
The patent replaces chemical synthesis methods with a biological fermentation system using genetically modified microorganisms. The introduced enzymatic pathways (lycopene-epsilon-cyclase and CCD1) naturally produce only the desired (R)-enantiomer through stereospecific catalysis, eliminating the formation of racemic mixtures while maintaining high productivity. This biological system substitutes for chemical methods that cannot achieve enantiomeric selectivity.
Solution Approach 2:
The patent changes the production parameter from chemical catalysis to enzymatic catalysis, which inherently provides stereospecificity. The introduced enzymes catalyze reactions with specific stereochemical outcomes, producing exclusively (R)-alpha-ionone. This parameter change from chemical to biological catalysis simultaneously achieves high productivity and enantiomeric purity without requiring additional separation steps.
3Productivity
If existing recombinant systems are used for alpha-ionone production, then fermentative production can be achieved, but the yields are low and substrate specificity is limited
Solution Approach 1:
The patent merges two specific enzymatic activities (lycopene-epsilon-cyclase and CCD1) into a coordinated biosynthetic pathway within the microorganism. This combination of enzymes creates an efficient metabolic route that converts simple substrates into alpha-ionone with high yield. The merged pathway overcomes the limitations of previous recombinant systems by integrating complementary enzymatic functions that work synergistically.
Solution Approach 2:
The patent introduces a universal biosynthetic pathway into the microorganism that can process simple substrates through the introduced enzymes to produce alpha-ionone. The system achieves multi-functionality by combining substrate conversion capabilities with stereospecific enzyme catalysis, allowing the microorganism to produce high yields of enantiomerically pure alpha-ionone from readily available precursors, overcoming the substrate specificity limitations of earlier systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the yield and purity of alpha-ionone, achieving enantiomerically pure (R)-alpha-ionone production with improved efficiency and sustainability compared to traditional methods, addressing the limitations of natural source extraction and chemical synthesis.
Implementation Method 1
A method involving the culturing of microorganisms with heterologous nucleotide sequences encoding enzymes like geranylgeranyl-diphosphate-synthase, isopentenyl-diphosphate-isomerase, phytoene-desaturase/dehydrogenase, phytoene synthase, lycopene-epsilon-cyclase, and carotenoid-cleavage-dioxygenase to fermentatively produce enantiomerically pure alpha-ionone
Implementation Method 2
The microorganism contains heterologous nucleotide sequences, which encode the enzymes geranylgeranyl-diphosphate-synthase, isopentenyl-diphosphate-isomerase (IPI), phytoene-desaturase/dehydrogenase (crtI), phytoene synthase (crtB), lycopene-epsilon-cyclase (EC) and carotenoid-cleavage-dioxygenase (CCD1)
Data Source
AI summary
The present invention concerns a method of producing and enantiomerically pure alpha-ionone. Further, the invention concerns a nucleic acid that comprises a sequence that encodes a lycopene-epsilon-cyclase (EC), a lycopene-epsilon-cyclase (EC), plasmids, which encode components of the alpha-ionone biosynthesis and a microorganism that contains heterologous nucleotide sequences which encode the enzymes geranylgeranyl-diphosphate-synthase, isopentenyl-diphosphate-isomerase (IPI), phytoene desaturase-dehydrogenase (crtI), phytoene synthase (crtB), lycopene-epsilon-cyclase (EC) and carotenoid-cleavage-dioxygenase (CCD1). Further, the invention concerns a method of producing highly pure epsilon-carotene.